Tmunity Therapeutics

BiotechnologySeries BPhiladelphia, UStmunity.com

Latest round

Series B

Last raised

Oct 2019

Total raised

$135M

Investors

11

About Tmunity Therapeutics

Tmunity Therapeutics Inc.Tmunity Therapeutics Inc. specializes in cell and gene therapy. Founded in 2015, the company is headquartered in Philadelphia, US. The founders include Arie Belldegrun and Bruce Levine.Tmunity is primarily focused on advancing the field of cell and gene therapy, offering innovative products and services designed to address critical healthcare challenges. The company's core offerings include proprietary platforms for T cell engineering, aimed at developing personalized therapies for various types of cancers and autoimmune diseases. By harnessing the power of the immune system, Tmunity's solutions enhance patient outcomes and expand treatment options. Targeted towards healthcare providers and research institutions, the company serves a client base that includes hospitals, academic medical centers, and biotechnology firms across North America and Europe.Tmunity generates revenue through strategic partnerships and collaborative agreements with biotechnology and pharmaceutical companies. These transactions often involve joint development agreements, allowing Tmunity and its partners to advance specific therapeutic candidates. Additionally, the company offers customized services related to its T cell engineering platforms.Tmunity's strategy for future growth includes the development of new products that leverage their T cell engineering technology, targeting the launch of several innovative therapies within the next few years. The company aims to expand into new markets, particularly Europe and Asia, by 2025., which may further influence their strategic direction and product offerings.

Who invested in Tmunity Therapeutics

11 investors across 3 rounds

See all investors in Tmunity Therapeutics

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series B

    Oct 22, 2019

    Amount

    $75M

    Investors

    Locked

  2. Series A

    Feb 6, 2018

    Amount

    $50M

    Investors

    Locked

  3. Seed

    Jan 12, 2016

    Amount

    $10M

    Investors

    Locked

Questions about Tmunity Therapeutics

Who invested in Tmunity Therapeutics?

Tmunity Therapeutics has 11 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Tmunity Therapeutics raised?

Tmunity Therapeutics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.

When did Tmunity Therapeutics last raise money?

Tmunity Therapeutics's most recent round on record is a Series B, in Oct 2019.

What does Tmunity Therapeutics do?

Tmunity Therapeutics is a biotechnology company.

Where is Tmunity Therapeutics headquartered?

Tmunity Therapeutics is headquartered in Philadelphia, US.

Which VCs invest in companies like Tmunity Therapeutics?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Tmunity Therapeutics's stage. Their profiles are linked below.

Raising like Tmunity Therapeutics? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.